Skip to content
Likelier

Action vs. inaction: sources for each choice

Pursue aggressive cancer treatment at end of stage vs. integrating palliative care early

If you act

Pursue aggressive cancer treatment (standard oncology, no early palliative integration)

No regret rate given

If you don't

Integrate palliative care from diagnosis (alongside oncology)

No regret rate given

No figure is shown: no source gives the share of people who regret each choice, measured the same way for both. What each source measures is described below.


Health

Last reviewed 2026-11-21

Evidence quality 4.13/5

Eight-dimension review score against the quality rubric . Each dimension scored 1–5.

D1 Source verification
4/5
D2 Source authority & independence
4/5
D3 Regret-rate accuracy
3/5
D4 Source comparability
4/5
D5 Gilovich pattern
5/5
D6 Prose quality
5/5
D7 Caveat completeness
4/5
D8 Sample quality
4/5
Average 4.13/5
A flat vector illustration of a hospital IV drip on one side and a simple comfortable chair by a window on the other
Sources and context only: the studies below measure outcomes, risks or regret scores, not the share of people who regret each choice measured the same way for both, so this page shows no figure.

If you act

Pursue aggressive cancer treatment (standard oncology, no early palliative integration)

No regret rate given

No source gives the share of people who regret this choice, measured the same way as for the other choice, so no figure is shown.

Bereaved caregivers of deceased cancer patients whose relative received aggressive end-of-life care (Tönnies et al. 2021, n=84 of 298 caregivers)

bereaved caregiver surveyed after the patient's death

If you don't

Integrate palliative care from diagnosis (alongside oncology)

No regret rate given

No source gives the share of people who regret this choice, measured the same way as for the other choice, so no figure is shown.

Bereaved caregivers of deceased cancer patients whose relative did not receive aggressive end-of-life care (Tönnies et al. 2021, n=184 of 298 caregivers)

bereaved caregiver surveyed after the patient's death

Action vs. inaction: sources for each choice

Related decisions

Semantically similar decisions — same territory, different trade-offs.

Health

MAID vs hospice

Figure for each choice (the measure is named on the page)

Health

Alt-only vs. conventional cancer

Figure for each choice (the measure is named on the page)

Health

Dialysis vs. conservative care

Figure for each choice (the measure is named on the page)

Health

Pursue longevity vs accept aging

Figure for each choice (the measure is named on the page)

Health

Advance directive timing

Figure for each choice (the measure is named on the page)

HealthDirect

Early diagnosis

% who regret this choice

Inaction dominates

Inaction regret 1.3× higher

family

Nursing home vs home care

Figure for each choice (the measure is named on the page)

Health

Intervene in rehab vs wait

Figure for each choice (the measure is named on the page)

No direct measurement of patients’ regret exists for either choice. The closest measure is a decision-regret score reported by bereaved caregivers, and no study we found follows patients who chose each path. This page gives sources and context and shows no figure.

A 2021 study in Frontiers in Oncology surveyed 298 bereaved caregivers of people who died of cancer. Caregivers whose relative had received aggressive end-of-life care reported significantly more decision regret on the Decision Regret Scale than caregivers whose relative had not. The study reports that such care occurs frequently in European health care and is associated with poorer mental health in bereaved caregivers.

A 2010 randomised trial in the New England Journal of Medicine, in patients with newly diagnosed metastatic non-small-cell lung cancer, compared early palliative care integrated with standard oncologic care against standard care alone. The early palliative care group had better quality of life and mood, less aggressive care at the end of life, and longer survival. The trial measured those outcomes and did not measure regret.

The two studies differ in design, population and country, and the caregiver study compared two groups it did not assign. Its label of aggressive care refers to treatment near the end of life, so it does not describe every decision to pursue cancer treatment.

Sources: action

Claim ledger

Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.

2/2 sources independently verified verbatim against the cited source

  1. [1] Frontiers in Oncology — Aggressiveness of Care at the End-of-Life in Cancer Patients and Its Association With Psychosocial Functioning in Bereaved Caregivers Verified
    Aggressiveness of Care at the End-of-Life in Cancer Patients and Its Association With Psychosocial Functioning in Bereaved Caregivers
    Statistic
    Among 298 bereaved caregivers of deceased cancer patients, those whose relative received aggressive end-of-life care (AOC) reported significantly higher decision regret on the Decision Regret Scale than non-AOC caregivers (mean 43.3 vs 32.6 on the 0–100 scale; Cohen's d = 0.49, 95% CI 0.23–0.76)
    Excerpt
    “"Bereaved AOC caregivers experienced significantly more decision regret compared to non-AOC caregivers (Cohen's d = 0.49, 95% CI [0.23, 0.76]). [...] AOC occurs frequently in European health care and is associated with poorer mental health outcomes in bereaved caregivers." ”
    Source data from
    2021-06-04
    Accessed
    2026-11-21
    Verification
    Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
    Calculation
    Survey of 298 bereaved caregivers using the Decision Regret Scale. Cited for the comparison of caregiver decision regret between aggressive and non-aggressive end-of-life care.
  2. [2] New England Journal of Medicine — Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer Verified
    Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
    Statistic
    Randomised trial: early palliative care integration in metastatic NSCLC produced better quality of life, less aggressive end-of-life care, AND longer survival (11.6 vs 8.9 months) compared with standard oncology care alone
    Excerpt
    “We randomly assigned patients with newly diagnosed metastatic non-small-cell lung cancer to receive either early palliative care integrated with standard oncologic care or standard oncologic care alone. [...] Patients assigned to early palliative care had a better quality of life than did patients assigned to standard care [...] ”
    Source data from
    2010-08-19
    Accessed
    2026-11-21
    Verification
    Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
    Calculation
    Randomised trial of early palliative care in metastatic non-small-cell lung cancer. Cited for outcomes, including aggressive end-of-life care. It does not measure regret.

Sources: inaction

Claim ledger

Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.

2/2 sources independently verified verbatim against the cited source

  1. [1] New England Journal of Medicine — Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer Verified
    Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
    Statistic
    Randomised trial of 151 patients with metastatic NSCLC: early palliative care gave better quality of life, fewer depressive symptoms, less aggressive end-of-life care (33% vs 54%), and longer median survival (11.6 vs 8.9 months) than standard oncology care alone
    Excerpt
    “Among patients with metastatic non-small-cell lung cancer, early palliative care led to significant improvements in both quality of life and mood. As compared with patients receiving standard care, patients receiving early palliative care had less aggressive care at the end of life but longer survival.”
    Source data from
    2010-08-19
    Accessed
    2026-11-21
    Verification
    Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
    Calculation
    Same trial, cited for outcomes of early palliative care alongside standard care. It does not measure regret.
  2. [2] Frontiers in Oncology — Aggressiveness of Care at the End-of-Life in Cancer Patients and Its Association With Psychosocial Functioning in Bereaved Caregivers Verified
    Aggressiveness of Care at the End-of-Life in Cancer Patients and Its Association With Psychosocial Functioning in Bereaved Caregivers
    Statistic
    Bereaved caregivers of cancer patients who did NOT receive aggressive end-of-life care reported a mean decision-regret score of 32.6/100 (SD 21.93, n=184) on the Decision Regret Scale — significantly lower than the 43.3/100 of aggressive-care caregivers (Cohen's d = 0.49)
    Excerpt
    “"Bereaved AOC caregivers experienced significantly more decision regret compared to non-AOC caregivers (Cohen's d = 0.49, 95% CI [0.23, 0.76]). [...] AOC occurs frequently in European health care and is associated with poorer mental health outcomes in bereaved caregivers." ”
    Source data from
    2021-06-04
    Accessed
    2026-11-21
    Verification
    Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
    Calculation
    Same caregiver survey, cited for decision regret among caregivers whose relative did not receive aggressive end-of-life care.

Caveats

Neither side carries a figure. Caregiver decision regret is reported by relatives after a death, not by patients. The trial concerns one cancer type and was not designed to measure regret.

Raw data: /api/decisions.json

Recently viewed on this device